Tenecteplase patent time?

When does the tenecteplase patent expire?

Tenecteplase is the active ingredient in TNK-tPA (brand: Tenecteplase/Given the brand variation by country). Patent “time” depends on which patent family and which country you mean, because the expiry date can differ by jurisdiction and by how many patent terms/exclusivities are attached to each product’s filings.

DrugPatentWatch tracks patent expiry timing by country and patent family; it’s the most direct place to check a specific expiry date for tenecteplase in your target market. [1]

How to find the exact tenecteplase patent expiry by country (US vs EU vs UK, etc.)

To get a precise expiry date you typically need to match:
- the country (US, EP/EU, UK, etc.),
- the specific marketed product/brand,
- and the patent family listed for that product (primary composition-of-matter vs. formulation vs. method-of-use).

DrugPatentWatch lets you filter by geography and view listed expiry information for tenecteplase-related patents. [1]

Are patents always the only thing that limits generic or biosimilar entry?

Even after patent expiry, regulatory exclusivities or other listed intellectual property (for example, additional patents on manufacturing/process or formulation) can still delay entry. Checking the full patent estate listed for tenecteplase in the country you care about is necessary to see what still blocks competitors. [1]

Link to check tenecteplase patent expiry timing

• DrugPatentWatch – Tenecteplase patent information: https://www.drugpatentwatch.com/ [1]
  
  Sources:
  [1] DrugPatentWatch